Elanco Animal Health Reports the US FDA’s Approval of Credelio Quattro for Protection Against Parasites in Dogs
Shots:
- The US FDA has granted approval to Credelio Quattro (QM) for protection against parasites such as fleas, ticks, heartworms, roundworms, hookworms & tapeworms in dogs (≥8wks.), with its commercialization planned during Q1’25
- The drug is indicated to protect puppies weighing 3.3lbs from internal parasites, incl. zoonotic parasites like echinococcus tapeworm
- Credelio Quattro (lotilaner, moxidectin, praziquantel & pyrantel) are beef-flavored chewable tablets that kill ticks & fleas within 4hrs., offers 100% protection within a day & remains effective for a month. It further offers full safety from heartworm disease starting with the first dose
Ref: Elanco Animal Health | Image: Elanco Animal Health
Related News:- Elanco Animal Health Reports the US FDA’s Approval of Zenrelia (Ilunocitinib) to Treat Canine Dermatological Disorders
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
